|
1
|
Tripathi BK and Srivastava AK: Diabetes
mellitus: Complications and therapeutics. Med Sci Monit.
12:RA130–RA147. 2006.PubMed/NCBI
|
|
2
|
Bos M and Agyemang C: Prevalence and
complications of diabetes mellitus in Northern Africa, a systematic
review. BMC Public Health. 13:3872013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vlassara H and Uribarri J: Advanced
glycation end products (AGE) and diabetes: Cause, effect, or both?
Curr Diab Rep. 14:4532014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nowotny K, Jung T, Höhn A, Weber D and
Grune T: Advanced glycation end products and oxidative stress in
type 2 diabetes mellitus. Biomolecules. 5:194–222. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xie J, Méndez JD, Méndez-Valenzuela V and
Aguilar-Hernández MM: Cellular signalling of the receptor for
advanced glycation end products (RAGE). Cell Signal. 25:2185–2197.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ott C, Jacobs K, Haucke E, Navarrete
Santos A, Grune T and Simm A: Role of advanced glycation end
products in cellular signaling. Redox Biol. 2:411–429. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Toker A and Marmiroli S: Signaling
specificity in the Akt pathway in biology and disease. Adv Biol
Regul. 55:28–38. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jacot JL and Sherris D: Potential
therapeutic roles for inhibition of the PI3K/Akt/mTOR pathway in
the pathophysiology of diabetic retinopathy. J Ophthalmol.
2011:5898132011.PubMed/NCBI
|
|
9
|
Yau JW, Rogers SL, Kawasaki R, Lamoureux
EL, Kowalski JW, Bek T, Chen SJ, Dekker JM, Fletcher A, Grauslund
J, et al: Global prevalence and major risk factors of diabetic
retinopathy. Diabetes Care. 35:556–564. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tarr JM, Kaul K, Chopra M, Kohner EM and
Chibber R: Pathophysiology of diabetic retinopathy. ISRN
Ophthalmol. 2013:3435602013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Antonetti DA, Klein R and Gardner TW:
Diabetic retinopathy. N Engl J Med. 366:1227–1239. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zong H, Ward M and Stitt AW: AGEs, RAGE,
and diabetic retinopathy. Curr Diab Rep. 11:244–252. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goldman D: Müller glial cell reprogramming
and retina regeneration. Nat Rev Neurosci. 15:431–442. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shin ES, Sorenson CM and Sheibani N:
Diabetes and retinal vascular dysfunction. J Ophthalmic Vis Res.
9:362–373. 2014.PubMed/NCBI
|
|
15
|
Qin Q, Niu J, Wang Z, Xu W, Qiao Z and Gu
Y: Heparanase induced by advanced glycation end products (AGEs)
promotes macrophage migration involving RAGE and PI3K/AKT pathway.
Cardiovasc Diabetol. 12:372013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hou X, Hu Z, Xu H, Xu J, Zhang S, Zhong Y,
He X and Wang N: Advanced glycation endproducts trigger autophagy
in cadiomyocyte Via RAGE/PI3K/AKT/mTOR pathway. Cardiovasc
Diabetol. 13:782014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Smith LE, Shen W, Perruzzi C, Soker S,
Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, et al:
Regulation of vascular endothelial growth factor-dependent retinal
neovascularization by insulin-like growth factor-1 receptor. Nat
Med. 5:1390–1395. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Majka S, McGuire PG and Das A: Regulation
of matrix metalloproteinase expression by tumor necrosis factor in
a murine model of retinal neovascularization. Invest Ophthalmol Vis
Sci. 43:260–266. 2002.PubMed/NCBI
|
|
19
|
Gupta N, Mansoor S, Sharma A, Sapkal A,
Sheth J, Falatoonzadeh P, Kuppermann B and Kenney M: Diabetic
retinopathy and VEGF. Open Ophthalmol J. 7:4–10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lois N, McCarter RV, O'Neill C, Medina RJ
and Stitt AW: Endothelial progenitor cells in diabetic retinopathy.
Front Endocrinol (Lausanne). 5:442014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Joussen AM, Murata T, Tsujikawa A,
Kirchhof B, Bursell SE and Adamis AP: Leukocyte-mediated
endothelial cell injury and death in the diabetic retina. Am J
Pathol. 158:147–152. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kady N, Yan Y, Salazar T, Wang Q,
Chakravarthy H, Huang C, Beli E, Navitskaya S, Grant M and Busik J:
Increase in acid sphingomyelinase level in human retinal
endothelial cells and CD34+ circulating angiogenic cells isolated
from diabetic individuals is associated with dysfunctional retinal
vasculature and vascular repair process in diabetes. J Clin
Lipidol. 11:694–703. 2017. View Article : Google Scholar : PubMed/NCBI
|
